EGFR and neoplasm: The in vivo specificity of [68Ga]Ga-DFO-ZEGFR:2377 binding to EGFR in tumor xenografts was evaluated by presaturation of receptors using the monoclonal antibody cetuximab in tumor (Figure 6).